May 27th, 2015
Hosted by Cures Within Reach, the leading non-profit dedicated to medical research repurposing existing drugs and devices for new uses, this premier dinner event raises funds for Cures Within Reach while providing a high level networking space for the BioScience community, honoring leaders creating patient impact through their research, business and philanthropic achievements.
Celebrating the launch of CureAcceleratorTM, the world's first interactive, online platform dedicated to repurposing. Created by Cures Within Reach, platform built with a grant from the Robert Wood Johnson Foundation.
Patient Impact Legacy Award
Dr. Richard DiMarchi
Dr. DiMarchi's contributions in peptide & protein sciences consists of three decades of work in academia, the pharmaceutical industry and biotechnology companies. He is the Cox Distinguished Professor of Biochemistry and Gill Chair in Biomolecular Sciences at Indiana University. He is a co-founder of Ambrx, Inc., Marcadia Biotech, Assembly and Calibrium Biotech. He has served as a scientific advisor to multiple pharmaceutical companies and three venture funds; 5AM, TMP, and Twilight. He is Chairman of the Peptide Therapeutics Foundation and external board member at Assembly Biosciences and Ontarget Therapeutics.
Dr. DiMarchi is a retired Group Vice President at Eli Lilly & Company where for more than two decades he provided leadership in biotechnology, endocrine research and product development. He is readily recognized for discovery and development of rDNAderived Humalog® (LisPro-human insulin). As scientist and executive, Dr. DiMarchi also significantly contributed to the commercial development of Humulin®, Humatrope®, rGlucagon®, Evista®, and Forteo®. Read More